Advanced Recurrent Ovarian Cancer
Links shared publicly online about this topic
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival and an only modes” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 6:05 pm By:
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence http://mnt.to/3NP9
First Recurrent Gene Fusion Identified In Ovarian Cancer
medicalnewstoday.com — “Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by a” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2011 at 7:05 am By:
First Recurrent Gene Fusion Identified In Ovarian Cancer http://mnt.to/3ZMY #ovariancancer
Treatment for Advanced Ovarian Cancer Effective
disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancer” View full resource at disabled-world.com
Most Recently Shared on June 6, 2010 at 11:31 pm By:
Treatment for Advanced Ovarian Cancer Effective http://ff.im/-lA8Uw
Phase 2 study of aflibercept for the treatment of advanced ovarian cancer with ascites - MPR
empr.com — “Sanofi-aventis and Regeneron Pharmaceuticals announced data from a Phase 2 trial for their fusion protein product, aflibercept (VEGF Trap), in the treatment of advanced ovarian cancer patients with recurrent symptomatic malignant ascites (SMA).” View full resource at empr.com
Most Recently Shared on June 11, 2009 at 6:34 pm By:
MPR News: Phase 2 study of aflibercept for the treatment of advanced ovarian cancer with ascites: Sanof.. http://tinyurl.com/mobhuq
Ovarian Cancer: eMedicine Oncology
emedicine.medscape.com — “Overview: Ovarian cancer is the most common cause of cancer death from gynecologic tumors in the United States. Early disease causes minimal, nonspecific, or no symptoms. Therefore, most cases are diagnosed in an advanced stage. Overall, prognosis ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 12, 2010 at 6:04 pm By:
Ovarian Cancer: Study finds cytoreductive surgery safe and effective in platinum-sensitive recurrent ovarian cancer. http://bit.ly/9ZmUBA
Ovarian cancer vaccine: Can it prevent recurrence? - MayoClinic.com
mayoclinic.com — “Research continues to evaluate the role of an ovarian cancer vaccine to prevent recurrence.” View full resource at mayoclinic.com
Most Recently Shared on March 24, 2012 at 2:20 am By:
Ovarian cancer vaccine: Can it prevent recurrence?: Research continues to evaluate the role of an ovarian cancer... http://t.co/fbwU0zDZ
EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment
medicalnewstoday.com — “EGEN, Inc. announced that the first Phase II clinical trial utilizing EGEN-001 for the treatment of recurrent ovarian cancer is now open for enrollment. The trial is sponsored by the Gynecologic” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2010 at 6:05 pm By:
EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment http://mnt.to/3P6r #ovariancancer
Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer - Drugs.com MedNews
drugs.com — “THOUSAND OAKS, Calif., Amgen (Nasdaq AMGN) today announced AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial invo” View full resource at drugs.com
Most Recently Shared on October 11, 2010 at 11:06 pm By:
Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer: THOU... http://bit.ly/b2PL9F #drug
Ovarian Cancer
springer.com — “Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of ...” View full resource at springer.com
Most Recently Shared on March 16, 2012 at 6:27 pm By:
Ovarian Cancer: Second Editionseries:Cancer Treatment and ResearchOvarian carcinoma continues to be responsible ... http://t.co/GanmC9SK
Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer
medicalnewstoday.com — “Ovarian cancer is a major health concern for women and the identification of sensitive biomarkers for early detection and/or monitoring of disease recurrence is of high clinical relevance.” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2011 at 9:07 am By:
Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer http://t.co/7OgdD8rC #ovariancancer
Ovarian cancer advances when genes are silenced
eurekalert.org — “Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.” View full resource at eurekalert.org
Most Recently Shared on December 14, 2010 at 4:41 pm By:
Ovarian cancer advances when genes are silenced ---> http://dld.bz/ANpD
Ovarian cancer advances when genes are silenced
labspaces.net — “There are many mechanisms that alter the activity of genes -- direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.” View full resource at labspaces.net
Most Recently Shared on December 14, 2010 at 4:48 pm By:
Ovarian cancer advances when genes are silenced - http://is.gd/iJVou
Key advances in ovarian cancer (ASCO 2010 ) Video
vodpod.com — “Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses research demonstrating the effectiveness of combining bevacizumab with chemotherapy as first line treatment of ovarian cancer. A second key presentation was research indicating that PARP inhibitors are effective at treating not just ovarian cancer caused by BRCA mutation but also high grade serous cancer. If this result is confirmed in further studies, it wo” View full resource at vodpod.com
Most Recently Shared on July 22, 2010 at 9:59 pm By:
Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun
Ovarian cancer advances when genes are silenced
sciencedaily.com — “Researchers have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.” View full resource at sciencedaily.com
Most Recently Shared on December 14, 2010 at 3:38 am By:
Ovarian cancer advances when genes are silenced: Researchers have found evidence of epigenetics at work on a gen... http://bit.ly/hM8eZ9
7 Clues to Ovarian Cancer
webmd.com — “Seven symptoms often reported to doctors are associated with ovarian cancer, according to a new study from the U.K., dispelling the idea that the deadly cancer is a ''silent killer'' with few clues until the advanced stages.” View full resource at webmd.com
Most Recently Shared on August 25, 2009 at 11:47 pm By:
7 Clues to Ovarian Cancer: Seven symptoms often reported to doctors are associated with ovarian cancer, accordin.. http://bit.ly/17OJmo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Ovarian Cancer
The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Ovarian Cancer
The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.
-
Disabled World
Disabled World is managed by Lynn and Ian Langtree, a couple dedicated to assisting seniors and people with disabilities.
Advertisement

